Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Beijing Xuanyi Pharmasciences patents GABA(A) receptor subunits alpha1beta2gamma2 PAMs

Aug. 10, 2020

First-in-human data presented for NTRX-07

Aug. 7, 2020

Lundbeck discontinues phase II study of Lu-AF-11167

Aug. 6, 2020

MODAG completes first phase I study of Anle-138b

Aug. 6, 2020

Chinese researchers present new mu-opioid receptor agonists

Aug. 6, 2020

IBC-Ab002 shows promising safety and efficacy in models of AD

Aug. 6, 2020

Transplanted iPSCs are best of both ApoE models

Aug. 6, 2020

Probiotics affect brain peptidome via gut-brain axis

Aug. 5, 2020

Phase II trial of EPX-100 underway in children with Dravet syndrome

Aug. 5, 2020

AC Immune to advance anti-TDP-43 antibody toward clinical development

Aug. 5, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...